Press release: Health Panorama 2024: fact-based contribution to the dialogue for a sustainable healthcare system
Interpharma, the association of Switzerland’s research-based pharmaceutical industry, is committed to making the Swiss healthcare system fit for the future and, with the “Health Panorama 2024”, is providing the basis for a solution-oriented and fact-based discourse. Interpharma’s statistics publication offers a compact overview of the key facts, figures and developments in relation to the healthcare system, the pharmaceutical market and Switzerland’s position as a pharma hub.
In the 43rd issue of Health Panorama, we provide a compact overview of the key data and developments in relation to the healthcare system, the medication market, patient access and research and development, as well as Switzerland as a pharmaceutical and business hub.
In 2024, Health Panorama once again serves as a contribution to a constructive discussion about the healthcare system, about Switzerland as a business location and about the welfare of patients. The publication Health Panorama – the most important facts and figures on Switzerland’s health and pharmaceutical landscape is available to order or to download as a PDF on the Interpharma website. You can also find key facts and figures – including source references – online and to download in our data center.
René Buholzer, CEO of Interpharma, commented:
“A future-proof healthcare system is not conceived in isolated silos, but rather holistically. Health Panorama makes a fact-based contribution to this social and political discourse.”
Georg Därendinger
Head of Communication
+41 79 590 98 77
Most read articles
1 april 2025
Pharmaceutical Industry Day 2025: making the Swiss pharmaceutical industry more competitive
Interpharma, the association of Switzerland’s research-based pharmaceutical industry, was founded in Basel in 1933.
Interpharma informs the public about issues that are important to the research-based pharmaceutical industry in Switzerland, including the pharma market in Switzerland, healthcare and biomedical research.
Annual report
Information on our key figures and activities in the financial year 2024